MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Laboratory Investigation

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/labinvest.3700246PMID 15696185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology.

  2008cited by this paper
• Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice.

  2003cited by this paper
• Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition

  2003cited by this paper
• Rodent models of genetic disease.

  2003cited by this paper
• Necroinflammatory Liver Disease in BALB/c Background, TGF-β1-Deficient Mice Requires CD4+ T Cells1

  2003cited by this paper
• Microbial community in acidic hydrothermal waters of volcanically active White Island, New Zealand

  2002cited by this paper
• Genetics in Autoimmune Hepatitis

  2002cited by this paper
• The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity1

  2002cited by this paper
• Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis.

  2002cited by this paper
• In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket1

  2002cited by this paper
• Genetic Regulation of Autoimmune Disease: BALB/c Background TGF-β1-Deficient Mice Develop Necroinflammatory IFN-γ-Dependent Hepatitis1

  2001cited by this paper
• Mapping and identification of autoimmunity genes.

  2000cited by this paper
• Genetics of Systemic Autoimmunity in Mouse Models of Lupus

  2000cited by this paper
• Cytotoxic T lymphocyte antigen‐4 (CTLA‐4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

  2000cited by this paper
• Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

  2000cited by this paper
• Strain dependency of TGFbeta1 function during embryogenesis.

  1999cited by this paper
• Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

  1999cited by this paper
• Strain dependency of TGFβ1 function during embryogenesis

  1999cited by this paper
• Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis.

  1999cited by this paper
• Several common HLA-DR types share largely overlapping peptide binding repertoires.

  1998cited by this paper
• Histocompatibility gene mutation rates in the mouse: a 25-year review

  1997cited by this paper
• On naming H2 haplotypes: functional significance of MHC class Ib alleles.

  1997cited by this paper
• On naming H2 haplotypes: functional significance of MHC class Ib alleles.

  1997cited by this paper
• Autoimmune hepatitis.

  1996cited by this paper
• A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.

  1996cited by this paper
• Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.

  1995cited by this paper
• Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice.

  1995cited by this paper
• Advanced intercross lines, an experimental population for fine genetic mapping.

  1995cited by this paper
• Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.

  1995cited by this paper
• Cellular expression of tumour necrosis factor-α and interferon-γ in the liver biopsies of children with chronic liver disease

  1994cited by this paper
• Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease.

  1994cited by this paper
• HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients.

  1992cited by this paper
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease

  1992cited by this paper
• Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes

  1992cited by this paper
• Genetic analysis of autoimmune type 1 diabetes mellitus in mice

  1991cited by this paper
• Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1‐B8‐DR3 are independent risk factors

  1991cited by this paper
• A TCR gamma delta cell recognizing a novel TL-encoded gene product.

  1989cited by this paper
• Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes.

  1983cited by this paper
• HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.

  1980cited by this paper
• Increased Frequency of HLA‐DRW4 in Chronic Active Hepatitis 1

  1978cited by this paper
• Genetic factors in the development of chronic active hepatitis.

  1977cited by this paper
• Genetic analysis of patients with chronic active hepatitis.

  1975cited by this paper
• Association of autoimmune active chronic hepatitis with HL-A1,8.

  1972cited by this paper
• HISTOCOMPATIBILITY GENES OF MICE: XI. Evidence Establishing a New Histocompatibility Locus, H‐12, and New H‐2 Allele, H‐2bc1

  1971cited by this paper

• Genetic aspects of adult and pediatric autoimmune hepatitis: a concise review.

  2021cites this paper
• The Human Endolymphatic Sac and Inner Ear Immunity: Macrophage Interaction and Molecular Expression

  2019cites this paper
• Human Inner Ear Immune Activity: A Super-Resolution Immunohistochemistry Study

  2019cites this paper
• Cellular and Molecular Mechanisms of Autoimmune Hepatitis.

  2018cites this paper
• Appropriate Development of the Liver Treg Compartment Is Modulated by the Microbiota and Requires TGF-β and MyD88

  2014cites this paper
• Herb‐induced autoimmune‐like hepatitis in C57BL/6J mice

  2014influential citation
• Type 1 T Helper Cells Induce the Accumulation of Myeloid‐Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver

  2010cites this paper
• T Cell Production of IFN-+ CD 4 Fulminant Liver Inflammation Requires End-Organ Damage in a Mouse Model of

  2009cites this paper
• The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis

  2009cites this paper
• Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit

  2009cites this paper
• End-Organ Damage in a Mouse Model of Fulminant Liver Inflammation Requires CD4+ T Cell Production of IFN-γ but Is Independent of Fas1

  2009cites this paper
• Autoimmune liver disease and rheumatic manifestations

  2007cites this paper
• Bibliography. Current world literature. Vasculitis syndromes.

  2007cites this paper
• TGF-β1 Regulates Antigen-Specific CD4+ T Cell Responses in the Periphery1

  2007cites this paper
• Autoimmune liver disease

  2007cites this paper
• Autoimmune hepatitis. Part A: pathogenesis

  2007cites this paper
• Autoimmune liver disease

  2006cites this paper
• Self-antigen recognition by TGFβ1-deficient T cells causes their activation and systemic inflammation

  2006cites this paper
• Transforming growth factor-beta1, Th1 responses, and autoimmune liver disease.

  2005cites this paper
• Working together to provide research , education , and support for people affected by Primary Sclerosing Cholangitis PSC Partners Seeking a Cure Board Members :

  2005cites this paper
• Transforming growth factor‐β1, Th1 responses, and autoimmune liver disease

  2005cites this paper